Development of innovative medicines for cardiometabolic diseases and treating inflammation in atherosclerotic cardiovascular disease.
1 report, 1 independent
Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Development of innovative medicines for cardiometabolic diseases and treating inflammation in atherosclerotic cardiovascular disease.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Harbour BioMed focuses on solutions for metabolic and cardiovascular diseases.Sub-event
- Michael Rankowitz made the biggest insider purchase at Rupsi Airport on June 22, 2025.Sub-event
Drug candidates are being developed to treat cardiometabolic diseases and cardiovascular inflammation.1 source
Keep exploring
The entities involved
-
Rupsi Airport
airport in India
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireVeru to Report Fiscal 2025 Third Quarter Financial Results on August 12th MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on